Exploring Novel Frontiers: Leveraging STAT3 Signaling for Advanced Cancer Therapeutics

Taiwo Adesoye,Debasish Tripathy,Kelly K. Hunt,Khandan Keyomarsi
DOI: https://doi.org/10.3390/cancers16030492
2024-01-24
Cancers
Abstract:Signal Transducer and Activator of Transcription 3 (STAT3) plays a significant role in diverse physiologic processes, including cell proliferation, differentiation, angiogenesis, and survival. STAT3 activation via phosphorylation of tyrosine and serine residues is a complex and tightly regulated process initiated by upstream signaling pathways with ligand binding to receptor and non-receptor-linked kinases. Through downstream deregulation of target genes, aberrations in STAT3 activation are implicated in tumorigenesis, metastasis, and recurrence in multiple cancers. While there have been extensive efforts to develop direct and indirect STAT3 inhibitors using novel drugs as a therapeutic strategy, direct clinical application remains in evolution. In this review, we outline the mechanisms of STAT3 activation, the resulting downstream effects in physiologic and malignant settings, and therapeutic strategies for targeting STAT3. We also summarize the pre-clinical and clinical evidence of novel drug therapies targeting STAT3 and discuss the challenges of establishing their therapeutic efficacy in the current clinical landscape.
oncology
What problem does this paper attempt to address?
The paper attempts to address the issue of exploring the role and mechanisms of Signal Transducer and Activator of Transcription 3 (STAT3) in cancer treatment. Specifically: 1. **Mechanism of STAT3**: The paper provides a detailed introduction to the working principles of the STAT3 signaling pathway, including its structure, activation process, and how it transmits signals to the nucleus through phosphorylation to regulate the expression of downstream genes. 2. **Role of STAT3 in Cancer**: The paper discusses the abnormal activation of STAT3 in various cancers and points out that this activation is related to the occurrence, development, metastasis, and resistance to treatment of tumors. Additionally, it mentions that STAT3 may have tumor-suppressing functions in certain situations, depending on the specific tumor environment and genetic variations. 3. **Therapeutic Strategies Targeting STAT3**: The paper summarizes the current progress in preclinical and clinical research on new drug therapies targeting STAT3 and discusses the challenges faced by these therapeutic methods. In summary, the paper aims to provide a comprehensive overview of the mechanisms of the STAT3 signaling pathway in cancer and its potential as a therapeutic target.